AUROBINDO PHARMA LIMITED
-
Aurobindo gets USFDA nod for generic version of Novo Nordisk's Vagifem
The company also said the US drug watchdog, which inspected a formulations manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialties Ltd at Bhiwadi in Alwar, Rajasthan, between April 25 to May 3 this year, has classified the inspection as official action indicated (OAI).
-
Aurobindo Pharma receives Sebi's warning letter over ongoing USFDA audit
-
Aurobindo gets licence for supply of Pfizer’s Covid pill
-
Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
-
Merck moves US court against Aurobindo Pharma on diabetic drug Janumet
-
No significant impact of EMA order on Europe biz, says Aurobindo
-
Aurobindo Pharma gets USFDA nod for Esomol Hydrochloride Injection
-
Aurobindo Pharma to raise USD 350 million through QIP
-
Aurobindo Pharma may spend Rs 1,300 cr toward capex in FY15-16
Advertisement
Advertisement